omeprazole has been researched along with beta carotene in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Ciofani, G; Cuccurullo, F; de Gioia, S; Festi, D; Lapenna, D | 1 |
| Camilo, ME; Russell, RM; Serfaty-Lacrosniere, C; Tang, G | 1 |
| Oster-Jørgensen, E; Rasmussen, L | 1 |
| Alexandre-Gouabau, MC; Azais-Braesco, V; Borel, P; Duszka, C; Grolier, P; Lory, S; Nugon-Baudon, L | 1 |
| Brown, LM; Chang, YS; Fraumeni, JF; Gail, MH; Heinrich, J; Liu, WD; Ma, JL; Xu, GW; Yang, CS; You, WC; Zhang, L | 1 |
| Bavbek, N; Koçkar, C; Oztürk, M | 1 |
3 trial(s) available for omeprazole and beta carotene
| Article | Year |
|---|---|
Gastric acidity influences the blood response to a beta-carotene dose in humans.
Topics: Absorption; Adult; Aged; beta Carotene; Cross-Over Studies; Diet; Female; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole | 1996 |
An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.
Topics: Adult; Aged; Amoxicillin; Antioxidants; Ascorbic Acid; beta Carotene; China; Double-Blind Method; Drug Therapy, Combination; Female; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Phytotherapy; Plants, Medicinal; Precancerous Conditions; Prevalence; Selenium; Stomach Neoplasms; Treatment Outcome; Vitamin E | 2001 |
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; beta Carotene; Clarithromycin; Disulfides; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Sulfinic Acids | 2001 |
5 other study(ies) available for omeprazole and beta carotene
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Antioxidant properties of omeprazole.
Topics: Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Chlorides; Copper; Deoxyribose; Ferric Compounds; Hydrogen-Ion Concentration; Hypochlorous Acid; Omeprazole; Oxidation-Reduction | 1996 |
Blood response to a beta-carotene dose.
Topics: Anti-Ulcer Agents; beta Carotene; Gastric Emptying; Humans; Omeprazole | 1998 |
The bioavailability of alpha- and beta-carotene is affected by gut microflora in the rat.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; beta Carotene; Biological Availability; Carotenoids; Enzyme Inhibitors; Feces; Female; Germ-Free Life; Humans; Intestinal Mucosa; Intestines; Liver; Omeprazole; Rats; Rats, Inbred F344; Rats, Wistar; Vitamin A | 1998 |